Biotechnology
Walgreens slashes earnings guidance due to lower consumer spending, drop in Covid care demand
People make their way near a Walgreens pharmacy on March 09, 2023 in New York City. Leonardo Munoz | Corbis News | Getty Images Walgreens on Tuesday slashed its full-year earnings guidance as it fell short of Wall Street expectations for its fiscal third quarter due to lower consumer spending and a drop in demand […]
Read More
Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly’s experimental drug helped patients lose up to 24% of their weight after almost a year, the highest reduction seen in the obesity treatment space to date, according to new mid-stage clinical trial results released Monday. […]
Read More
Novo Nordisk says high-dose experimental obesity pill leads to 15% weight loss
Novo Nordisk said that it was cutting the supply of some doses of its popular obesity drug in the U.S. as it struggles to keep up with surging demand. Liselotte Sabroe | Afp | Getty Images Novo Nordisk‘s high-dose experimental obesity pill helped overweight or obese adults lose around 15% of their body weight, according […]
Read More
Pfizer to end development of experimental obesity pill due to elevated liver enzymes
Pavlo Gonchar | Lightrocket | Getty Images Pfizer on Monday said it would stop developing its experimental obesity and diabetes pill, lotiglipron, due to elevated liver enzymes in patients who took the drug once a day in mid-stage clinical studies. Those elevated enzymes often indicate damage to cells in the liver, but the pharmaceutical giant […]
Read More
Moderna files for FDA approval of updated Covid vaccine for fall
A vial and a medical syringe seen displayed in front of the Food and Drug Administration (FDA) of the United States and Moderna biotechnology company’s logos. FDA finds the COVID-19 vaccine. Pavlo Gonchar | LightRocket | Getty Images Moderna on Thursday applied for U.S. Food and Drug Administration approval of the biotech company’s updated Covid […]
Read More
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says
Respiratory syncytial virus vial. Manjurul | Istock | Getty Images Vaccinating one million adults ages 65 and above with a single RSV shot from Pfizer or GSK may prevent thousands of hospitalizations over two seasons of the virus, according to a Centers for Disease Control and Prevention analysis. A CDC medical officer presented the analysis, […]
Read More
Look at stay: President Biden and India Prime Minister Modi speak at the White Residence
(The stream is slated to commence at 12:45 p.m. ET. Be sure to refresh the web page if you do not see a video clip earlier mentioned at that time.) President Joe Biden and Primary Minister Narendra Modi of India will keep a joint press convention following their bilateral meeting Thursday. Later on, Modi will […]
Read More
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults 60 and older
A health worker prepares a flu vaccine shot before administering it to a local resident in Los Angeles, the United States, on Dec. 17, 2022. Xinhua News Agency | Getty Images An advisory committee to the Centers for Disease Control and Prevention on Wednesday recommended that adults ages 60 and above, after consulting their doctors, […]
Read More
Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations
Traders work on the floor of the New York Stock Exchange during morning trading, April 10, 2023. Michael M. Santiago | Getty Images The pharmaceutical industry’s largest lobbying group and two other organizations on Wednesday sued the Biden Administration over Medicare’s new powers to slash drug prices for seniors under the Inflation Reduction Act. Pharmaceutical […]
Read More
GSK says RSV vaccine for older adults provides protection over two seasons
Respiratory syncytial virus viral vaccine under research. Hailshadow | Istock | Getty Images GlaxoSmithKline on Wednesday said its vaccine to protect adults ages 60 and older from respiratory syncytial virus, or RSV, remained effective across two seasons of the disease. A single dose of the shot was 67.2% effective in preventing lower respiratory tract illness […]
Read More